Acorn Financial Advisory Services’s Collegium Pharmaceutical COLL Stock Holding History

Acorn Financial Advisory Services’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Sell	32,125 -3,006	-9%	-$103K	0.15%	74
2026 Q1	$1.16M	Sell	35,131 -536	-2%	-$22.7K	0.16%	67
2025 Q4	$1.65M	Sell	35,667 -384	-1%	-$16.1K	0.24%	45
2025 Q3	$1.26M	Sell	36,051 -1,181	-3%	-$41.1K	0.19%	56
2025 Q2	$1.1M	Sell	37,232 -1,427	-4%	-$40.7K	0.18%	62
2025 Q1	$1.15M	Buy	38,659 +9,979	+35%	+$305K	0.21%	58
2024 Q4	$822K	Sell	28,680 -1,429	-5%	-$47.3K	0.14%	80
2024 Q3	$1.16M	Sell	30,109 -833	-3%	-$29.7K	0.21%	55
2024 Q2	$996K	Sell	30,942 -8,338	-21%	-$289K	0.19%	66
2024 Q1	$1.52M	Sell	39,280 -7,597	-16%	-$266K	0.29%	44
2023 Q4	$1.44M	Sell	46,877 -1,377	-3%	-$34.5K	0.25%	60
2023 Q3	$1.08M	Buy	48,254 +333	+0.7%	+$7.59K	0.19%	78
2023 Q2	$1.03M	Sell	47,921 -1,826	-4%	-$41.5K	0.18%	81
2023 Q1	$1.19M	Sell	49,747 -3,662	-7%	-$97.1K	0.23%	64
2022 Q4	$1.24M	Sell	53,409 -3,649	-6%	-$73.6K	0.26%	53
2022 Q3	$914K	Sell	57,058 -5,473	-9%	-$96.5K	0.22%	69
2022 Q2	$1.11M	Sell	62,531 -2,272	-4%	-$38.2K	0.26%	55
2022 Q1	$1.32M	Sell	64,803 -5,034	-7%	-$95.1K	0.26%	65
2021 Q4	$1.3M	Buy	69,837 +1,025	+1%	+$20K	0.26%	63
2021 Q3	$1.36M	Buy	68,812 +12,090	+21%	+$261K	0.42%	63
2021 Q2	$1.34M	Buy	56,722 +993	+2%	+$22.9K	0.4%	73
2021 Q1	$1.32M	Buy	55,729 +2,105	+4%	+$50K	0.48%	59
2020 Q4	$1.07M	Buy	53,624 +14,331	+36%	+$280K	0.42%	70
2020 Q3	$818K	Buy	39,293 +9,725	+33%	+$176K	0.43%	67
2020 Q2	$517K	Sell	29,568 -48	-0.2%	-$940	0.36%	99
2020 Q1	$484K	Sell	29,616 -1,767	-6%	-$36.5K	0.48%	73
2019 Q4	$646K	Buy	+31,383	New	+$523K	0.54%	59

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Acorn Financial Advisory Services's COLL Position: Q2 2026 in Review

Acorn Financial Advisory Services reduced its Collegium Pharmaceutical (COLL) stake by 8.6% in Q2 2026, selling an estimated $103K and leaving 32,125 shares worth $1.16M. The position accounts for 0.15% of the portfolio, ranked #74.

Acorn Financial Advisory Services first reported a position in COLL in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.65M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Acorn Financial Advisory Services held 32,125 shares of Collegium Pharmaceutical worth $1.16M as of Q2 2026.
Acorn Financial Advisory Services sold 3,006 Collegium Pharmaceutical shares in Q2 2026, an estimated $103K.
Collegium Pharmaceutical made up 0.15% of Acorn Financial Advisory Services's portfolio in Q2 2026, its #74 holding.
Acorn Financial Advisory Services first reported a position in Collegium Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
Acorn Financial Advisory Services's Collegium Pharmaceutical position peaked at $1.65M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Acorn Financial Advisory Services's 13F filing for Q2 2026, filed 20 Jul 2026.